Xencor (XNCR) Enterprise Value (2013 - 2026)
Xencor's (XNCR) quarterly Enterprise Value came in at -$384.4 million in Q1 2026, down 334.1% year-on-year from $164.2 million in Q1 2025, and up 11.68% on a QoQ basis from -$435.2 million in Q4 2025.
Xencor (XNCR) Enterprise Value (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Enterprise Value data on file, last reported at -$384.4 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 334.1% year-over-year to -$384.4 million in Q1 2026; TTM through Mar 2026 was -$384.4 million, a 334.1% decrease from a year earlier, with the FY2025 full-year figure at -$435.2 million, up 4.01% from the prior year.
- Enterprise Value for Q1 2026 stood at -$384.4 million, up from -$435.2 million in the prior quarter.
- Over the last five years, Enterprise Value for XNCR reached as high as -$60.8 million in Q2 2024 and fell as low as -$551.2 million in Q4 2023.
- Historically, Enterprise Value has averaged -$238.5 million across 5 years, with a median of -$112.1 million in 2023.
- Across the five-year window, Enterprise Value jumped 79.54% in 2022 and plunged 563.28% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$96.4 million in 2022, then sank by 471.92% to -$551.2 million in 2023, then increased by 17.73% to -$453.4 million in 2024, then climbed by 4.01% to -$435.2 million in 2025, then advanced by 11.68% to -$384.4 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$384.4 million in Q1 2026, -$435.2 million in Q4 2025, and -$112.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -384.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -384.38 Mn |
| Dec 31, 2025 | -435.23 Mn |
| Sep 30, 2025 | -112.55 Mn |
| Jun 30, 2025 | -403.43 Mn |
| Mar 31, 2025 | -88.55 Mn |
| Dec 31, 2024 | -453.43 Mn |
| Sep 30, 2024 | -467.01 Mn |
| Jun 30, 2024 | -60.82 Mn |
| Mar 31, 2024 | -75.91 Mn |
| Dec 31, 2023 | -551.18 Mn |
| Sep 30, 2023 | -465.56 Mn |
| Jun 30, 2023 | -74.71 Mn |
| Mar 31, 2023 | -112.10 Mn |
| Dec 31, 2022 | -96.37 Mn |
| Sep 30, 2022 | -84.84 Mn |
| Jun 30, 2022 | -76.30 Mn |
| Mar 31, 2022 | -111.70 Mn |
| Dec 31, 2021 | -180.34 Mn |
| Sep 30, 2021 | -88.78 Mn |
| Jun 30, 2021 | -161.07 Mn |